Third-Party Payment Suspension: Saidal Defends the Legality of Its Pharmacies

Confronted with the suspension of third-party payment coverage decided by the CNAS, Saidal has stepped up to defend the legality of its pharmacies, challenging any questioning of its legal framework and intending to present its arguments to the relevant institutions in order to secure the lifting of the suspension and the restoration of third-party billing.

The Saidal Group asserted Sunday, in a press release, that its retail drug distribution activity rests on established legal, administrative, and institutional foundations. This response follows the decision by the National Social Insurance Fund for Salaried Workers (CNAS) to suspend, effective November 15, medication coverage under the third-party payment system across Saidal pharmacies. The measure impacts both insured citizens and uninsured indigent individuals.

To defend its stance, Saidal cited “the operating license issued by the Ministry of Health on December 27, 1997,” in accordance with the regulations then in force prior to the enactment of the 2018 Health Law.

The group stressed that this document “constitutes the legal and administrative foundation upon which its activity is based” and “remains valid.” It argues that Law No. 18-11 of July 2, 2018, “provided neither explicitly nor implicitly for its cancellation or expiration,” and contains “no provision requiring its renewal.”

Saidal also pointed to the decision of the State Holdings Council, bearing number 05/197/11/01/2025, which entrusted it with managing the former national drug distribution company Endimed, along with all its tangible and intangible assets, including “the operating authorization for the activity.”

The group presented this ruling as “a fundamental institutional reference” to govern this activity and guarantee its continuity. It thus maintains that the initial permit and the management transfer form the twin pillars of its pharmacies’ legality.

Nevertheless, it should be noted that the root of this standoff between the two institutions lies in the fact that the file raises questions regarding the compliance of their legal status with current provisions governing pharmacy practice. Article 249 of the Health Law notably stipulates that “the pharmacist is the sole owner and manager of the business goodwill of the dispensary they hold.” Applying this rule to public entities inherited from Endimed sits at the very heart of the dispute.

CNAS Cites Health Ministry Reservations

The suspension stems from a directive issued by the CNAS General Directorate, numbered 2751 and addressed to agency directors. In it, the fund cites information relayed by the Ministry of Labor, based on findings provided by the Ministry of Health, highlighting a “non-compliance of the legal and legislative framework of the licenses governing the pharmaceutical activity carried out by Saidal pharmacies,” formerly Endimed.

Consequently, local agencies were instructed to notify the affected dispensaries that they must no longer receive or accept medical prescriptions nor dispense medications under the third-party payment scheme, for both social security beneficiaries and uninsured low-income patients alike.

For its part, Saidal indicated its preference for dialogue with the relevant authorities. The group affirmed it is pursuing “steps and contacts with the concerned bodies” to clarify the legal and regulatory aspects tied to its operations and reach solutions enabling the resumption of third-party coverage.

Saidal clarified that this approach aims to “preserve the rights of insured citizens and ensure they are not adversely affected in their access to medicines and pharmaceutical services.”

Beyond this regulatory controversy, the suspension of third-party payment raises pressing questions about its fallout for social security beneficiaries, particularly those accustomed to obtaining their prescriptions at the group’s pharmacies. The CNAS measure halts direct coverage for purchases made at these outlets under the third-party system. Insured patients will therefore have to turn to other contracted pharmacies to continue benefiting from this mechanism. Purchases made at Saidal pharmacies will no longer be eligible for reimbursement under this agreement starting from the decision’s effective date.

Addressing patient concerns, the National Union of Dispensing Pharmacists (SNAPO) advised affected beneficiaries to retrieve their Chifa cards from Saidal pharmacies and visit a private dispensary contracted with the CNAS to retain third-party payment access. This alternative should enable patients to continue their treatments without having to pay upfront for their medications every time.

In closing, the group reiterated its commitment to carrying out its missions “in compliance with the laws and regulations of the Republic.” It also sought to reassure patients and partners of its determination to ensure operational continuity through “institutional dialogue and coordination with the various stakeholders involved.”

It now remains to be seen whether discussions among the various institutions will resolve the disagreements over the legal status of these dispensaries and restore the third-party payment system, on which many social security beneficiaries rely.